THIRD HARMONIC BIO INC's ticker is and the CUSIP is 88427A107. A total of 63 filers reported holding THIRD HARMONIC BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $45,656 | +1281.8% | 3,512 | +903.4% | 0.00% | – |
| Q1 2024 | $3,304 | -84.6% | 350 | -82.1% | 0.00% | – |
| Q4 2023 | $21,425 | +56.7% | 1,953 | -8.7% | 0.00% | – |
| Q3 2023 | $13,674 | -49.3% | 2,140 | -61.9% | 0.00% | -100.0% |
| Q2 2023 | $26,994 | +269840.0% | 5,612 | +131.3% | 0.00% | – |
| Q1 2023 | $10 | +42.9% | 2,426 | +45.6% | 0.00% | – |
| Q4 2022 | $7 | – | 1,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $52,466,802 | 6.53% |
| Stonepine Capital Management, LLC | 2,793,149 | $13,435,047 | 4.85% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $8,658,000 | 1.28% |
| BVF INC/IL | 4,365,933 | $21,000,138 | 0.58% |
| COMMODORE CAPITAL LP | 993,294 | $4,777,744 | 0.54% |
| Orbimed Advisors | 5,779,071 | $27,797,332 | 0.50% |
| Bain Capital Life Sciences Investors, LLC | 640,631 | $3,081,435 | 0.32% |
| EcoR1 Capital, LLC | 2,088,780 | $10,047,032 | 0.25% |
| GENERAL ATLANTIC, L.P. | 2,958,762 | $14,231,645 | 0.22% |
| Boxer Capital, LLC | 570,417 | $2,744 | 0.13% |